Skip to main content
Home
  • 服务
    服务

    我们的服务涵盖产品开发和商业化的整个生命周期,既适用于小型本地试验,也适用于大型全球项目。

    Read More
    临床研究服务 商业定位 咨询服务 早期服务 战略性解决方案 语言服务 实验室服务 医学影像服务 真实世界洞察 研究中心及患者解决方案
    clinical-trials-china.jpeg
    COVID-19的临床试验

    Clinical trials during COVID-19.

    clinical-trials-china-2.jpeg
    研究中心和患者

    研究中心和患者识别,入组和参与

  • 治疗领域
    治疗领域

    我们在广泛的治疗领域拥有丰富的经验。我们管理所有主要地区的研究,与世界领先的研究人员建立了稳固的工作关系。

    Read More
    心血管系统 细胞和基因疗法(CGT) 中枢神经系统 内分泌与代谢疾病 感染性疾病 内科与免疫学 医疗器械 肿瘤学 儿科学 罕见病与孤儿病 移植免疫学 女性健康
    icon-china-mega-menu-image.jpeg
    疫苗

    ICON 领导了 18 种疫苗的开发,获得了 FDA/EMA 的批准,其中包括世界上第一个获批的 COVID-19 疫苗

    icon-china-mega-menu-image-2.jpeg
    治疗领域洞察

    ICON 的治疗专家定期为行业出版物内容做出贡献。

  • 加入我们
  • 新闻和活动
  • ICON中国
    ICON中国
    Read More
    ICON中国 公司历史 我们的荣誉 Leadership 联系我们
    Responsible business practice indicators
    环境、社会与公司治理(ESG)

    ICON Cares 代表我们致力于关爱每一个人、环境与社区,并带来积极改变的承诺。

    Medical analytics presentation preview
    医疗智能赋能

    推动临床研究不断前行

  • 中国大陆办公室
  • 商务合作
  1. Home
  2. Innovation
  3. FLEX ADVANTAGE for Adaptive Trials

FLEX ADVANTAGE for Adaptive Trials

Our technology allows companies to support adaptive randomisation trials efficiently while maintaining integrity

FLEX ADVANTAGE is ICON's proprietary Interactive Response Technology (IRT) platform for managing patient randomisation, investigator sites and clinical supplies specifically for adaptive trials. It is part of the ICONIK Informatics Hub.

ICON’s understanding of agency requirements, vast experience in adaptive trials, and ADDPLAN technoloogy, uniquely positions us in the industry as a top innovator in this field. Unlike conventional trials, many adaptive randomisation schemes require recalculation of the treatment assignments probabilities during the trial's conduct.

Regulatory agency concerns

Key concerns for regulatory agencies in adaptive trials include the protection, security, and safeguards against operational bias. Regulatory agencies need assurance that the sponsor, project team, patients, and principal investigators were appropriately firewalled from access to interim results.

By implementing FLEX ADVANTAGE, ICON can satisfy those requirements and concerns. Additionally, we have well‑established workflow practices with SOPs reflecting the requirements of adaptive trials, as shown below.

FDA guidance

There are a range of adaptive designs and statistical software design packages available to bring benefits in all the phases of clinical drug development.

However, as noted in the FDA guidance document, maintaining the integrity of the trial by not introducing any operational bias and inadvertently breaking the blind are the key elements of the execution. This emphasises the need to ensure that the validity and integrity of the trial are maintained when using adaptive design:

  • Validity: To ensure validity, companies need to ensure that correct statistical inferences are maintained, assuring consistency between different stages of the study and minimising operational bias.
  • Integrity: To ensure that integrity of the trial is maintained, companies need to focus on pre-planning and maintaining the blind (who sees what, when, and to what effect).
  • Rules: Adaptive design requires the trial to be conducted in multiple stages with access to accumulating data, one or more rules applied at the interim. This definition rule includes any group sequential designs, response adaptive, sample size re-estimation and flexible designs.

Role based data access

Randomisation and drug supply are encrypted in the system so access to this data is limited and role-based. Therefore, FLEX ADVANTAGE is able to provide unblinded information to the appropriate people:

  • Audit tracking capabilities capture information on who saw the data, and when.
  • The operational team can update the database in real time.
  • The clinical supplies team can see drug supply inventory.
  • CRAs can review enrollment, and specific information to ensure the database is always inspection ready.
  • DMC and independent statistical centre are unblinded and have access to the DMC repository that is web-based and holds DMC reports and information.
  • ICON's team of medical experts review the data in real time and raise medical queries.
  • In parallel statisticians and data managers review the data and raise appropriate related queries.

ICON's leading edge technologies FLEX ADVANTAGE and ADDPLAN combined with our expertise in adaptive trials make adaptive trials a reality for our clients.

Whitepaper

Executing Efficient and Compliant Adaptive Trials

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

Related Information

Whitepaper

White paper operational challenges of Adaptive Trials

Webpage

Adaptive Design Trials

Factsheet

Flex Advantage Slipsheet

Webpage

Clinical Research Services

Webpage

Commercialisation and Outcomes

Site Branding
    ICON plc
  • Contact
  • Results & Reports
For Clients
  • 我们的服务
  • 治疗领域
ICON for
  • 新 闻
  • 加入我们
News & Events
  • 中国大陆办公室
  • 商务合作
Socials
  • WeChat QR code

Legal Footer

  • © 2025 ICON plc
  • Disclaimer
  • Privacy
  • Cookies
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption